Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBDs): What the Endocrinologist Needs to Know.
Zangeneh, Farhad; Clarke, Bart L; Hurley, Daniel L; Watts, Nelson B; Miller, Paul D.
; 20(5): 500-16, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24325991
The demise of calcium-based phosphate binders-is this appropriate for children?
[New Developments in CKD-MBD. How to "Thinking Global! Acting Local" for treating CKD-MBD].
[New Developments in CKD-MBD. Strategies for the management of predilalysis CKD-MBD].
[Chronic kidney disease and nutrition].
What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials?
Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children.
CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.
[Treatment of CKD-MBD targeting the parathyroid gland].
Bone and kidney disease: diagnostic and therapeutic implications.
[New Developments in CKD-MBD. Cell Biology of parathyroid in CKD].